Despite the huge potential of the Chinese market, its complex market structure, policies and regulations and technical safety supervision often make some overseas in vitro diagnostic companies passive.
This webinar will conduct a comprehensive analysis and interpretation on topics such as Chinese market size, market access and product registration, laws and regulations, and technical safety supervision of Chinese IVD industry, helping overseas IVD brands to gain comprehensive insight into Chinese IVD industry market, so as to achieve localized development in such an important global market.
Enter the Chinese IVD market
13 October 2022
Clinical Laboratory Growth in China：From Clinical Work to Science Development in Nanfang hospital
Overview of China IVD Industry and Its Future Development
An overview to IVD Registration in China
IVD Regulatory Pathway in China
Roche Diagnostics in China's new development pattern
Prof Lei Zheng: Dean of the Department of Laboratory, Medicine Nanfang Hospital, Southern Medical University
Karen Dai: General of CACLP
Dr Zhen Liu: Vice General Manager of Beijing Zhongguancun Shuimu Medical Technology Co., Ltd.
Qi Li: Head of Quality and Regulatory Affairs, Beckman Coulter, China
Luca Xu: Head of Corporate Affairs & Market Access, Roche Diagnostics (Shanghai) Ltd.
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.